Nicole Campbell

@drnicolecampbell.bsky.social

Immunology researcher 👩🏼‍🔬 & amateur baker👩🏼‍🍳 working on tumour immunology & type I interferons (especially IFN-epsilon!) @ Hudson Institute of Medical Research, Melbourne 🇦🇺

Fantastic Hertzog oration at this year’s #lorneiandi from @mgalejr.bsky.social !

Victorian Infection and Immunity Network@theviin.bsky.social · 7mo ago

This year’s Hertzog Oration at #lorneiandi was delivered by the preeminent Michael Gale Jr. @mgalelab.bsky.social!🧬 From showcasing his pioneering research on the RIG-I pathway to future therapeutic applications, Prof. Gale's work has changed how we fight RNA viruses-from HCV to emerging flavivirus.

Q for my fellow scientists: you reviewed or authored a paper & when you see all of the reviewers’ comments, it is obvious one reviewer’s was written by ChatGPT, which all relate to the paper’s writing style rather than the actual science presented. Do you contact the handling editor? #sciencesky #AI

I've been on a bsky hiatus but I'm back to tell you to read this very cool paper if you're interested in IFNs & host-pathogen interactions! Our fav constitutively-expressed IFN, IFN-epsilon, facilitates immune evasion by Neisseria gonorrhoeae via modulation of sialic acid metabolism #immunosky

Waggoner Lab@labwaggoner.bsky.social · last yr.

Interferon-epsilon, an estrogen-induced type I interferon, is uniquely exploited by Neisseria gonorrhoeae via effects on sialic acid metabolism @cp-cellhostmicrobe.bsky.social www.cell.com/cell-host-mi...

Super cool new ovarian cancer research from the Bilandzic group at @hudsonresearch.bsky.social ! #ovariancancer #metastasis #immunosuppression

Hudson Institute of Medical Research@hudsonresearch.bsky.social · 2y ago

Dr Maree Bilandzic's latest research reveals that KRT14-positive leader cells drive #OvarianCancer metastasis by suppressing the immune system & the loss of these leader cells impaired metastasis without affecting tumour cell proliferation. Read more: bit.ly/41Ck5lU @ocrfaustralia.bsky.social

An advanced-stage tumor after 8 weeks, showing specific areas where cancer-spreading leader cells (KRT14+ LCs) and immune-suppressing cells (Tregs) are concentrated, driving tumor growth and immune evasion

I am incredibly fortunate and delighted to have been awarded a NHMRC Emerging Leadership Level 1 Investigator Grant this year! 🥳 This funding will provide crucial support for my research on interferon epsilon in cancer over the next 5 years. @hudsonresearch.bsky.social #nhmrc #investigatorgrant

NHMRC Investigator grant success 2025

Research into autoinflammatory diseases, hypertension, cancer and perinatal brain injury has been funded by NHMRC Investigator grants.

hudson.org.au

“It is a great shame that Ireland is a special case, but the shame is not Ireland’s.” ~Mark O’Connell The Irish Times ☕️🥐

Bild